Drug-likeness approach of 2-aminopyrimidines as histamine H3 receptor ligands
Bassem Sadek,1 Annemarie Schreeb,2 Johannes Stephan Schwed,2,3 Lilia Weizel,2 Holger Stark3 1Department of Pharmacology and Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates; 2Biocenter, Institute of Pharmaceutical Chemistry, Johann...
Main Authors: | Sadek B, Schreeb A, Schwed JS, Weizel L, Stark H |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-09-01
|
Series: | Drug Design, Development and Therapy |
Online Access: | http://www.dovepress.com/drug-likeness-approach-of-2-aminopyrimidines-as-histamine-h3-receptor--peer-reviewed-article-DDDT |
Similar Items
-
Anticonvulsant effects of isomeric nonimidazole histamine H3 receptor antagonists
by: Sadek B, et al.
Published: (2016-11-01) -
Anxiolytic and antidepressant-like activities of the novel and potent non-imidazole histamine H3 receptor antagonist ST-1283
by: Bahi A, et al.
Published: (2014-05-01) -
Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands.
by: David Schaller, et al.
Published: (2019-01-01) -
Novel chalcone-based fluorescent human histamine H3 receptor ligands as pharmacological tools
by: Holger eStark
Published: (2012-03-01) -
Multiple Targeting Approaches on Histamine H3 Receptor Antagonists
by: Mohammad eKhanfar, et al.
Published: (2016-05-01)